AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 71 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51,005,369 | -20.9% | 3,758,686 | 0.0% | 3.22% | -23.8% |
Q2 2023 | $64,461,465 | -15.0% | 3,758,686 | 0.0% | 4.22% | -12.9% |
Q1 2023 | $75,812,697 | -31.2% | 3,758,686 | 0.0% | 4.85% | -25.8% |
Q4 2022 | $110,129,500 | +76.7% | 3,758,686 | 0.0% | 6.54% | +80.2% |
Q3 2022 | $62,319,000 | +6.1% | 3,758,686 | 0.0% | 3.63% | -25.9% |
Q2 2022 | $58,748,000 | -14.7% | 3,758,686 | 0.0% | 4.89% | -6.4% |
Q1 2022 | $68,897,000 | +55.5% | 3,758,686 | 0.0% | 5.23% | +102.0% |
Q4 2021 | $44,315,000 | -43.8% | 3,758,686 | 0.0% | 2.59% | -44.6% |
Q3 2021 | $78,857,000 | -8.1% | 3,758,686 | 0.0% | 4.67% | -5.6% |
Q2 2021 | $85,811,000 | – | 3,758,686 | – | 4.95% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 3,758,686 | $78,857,000 | 4.67% |
RA Capital Management | 8,263,982 | $173,378,000 | 2.40% |
Cormorant Asset Management, LP | 2,030,691 | $41,962,000 | 1.70% |
SECTORAL ASSET MANAGEMENT INC | 341,367 | $7,162,000 | 0.60% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 714,285 | $14,986,000 | 0.29% |
Baker Brothers Advisors | 1,652,171 | $34,663,000 | 0.15% |
Old Well Partners, LLC | 12,600 | $264,000 | 0.14% |
Orbimed Advisors | 535,714 | $11,239,000 | 0.12% |
Parkwood LLC | 48,059 | $1,008,000 | 0.12% |
Darwin Global Management, Ltd. | 12,484 | $262,000 | 0.05% |